Lafutidine Tablet (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical studies with treatment for up to 8 weeks showed healing in most patients within 8 weeks, although the healing period may occasionally vary by patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical studies with treatment for up to 6 weeks showed healing in most patients within 6 weeks, although the healing period may occasionally vary by patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. Clinical studies with treatment for up to 2 weeks showed healing in most patients within 2 weeks, although the healing period may occasionally vary by patient. 4. Combination antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafudidine per administration, given twice orally (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafuditine orally twice daily.

This medication should not be used in patients with hypersensitivity to any of its components. It contains lactose and should not be taken by patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Administration should be cautious in patients with a history of hypersensitivity reactions to the drug, those with liver or kidney dysfunction, patients on dialysis, and the elderly. The drug can occasionally cause severe allergic reactions such as shock or anaphylaxis, so symptoms should be monitored closely after administration. Liver function impairment or jaundice may occur, thus regular liver function tests should be conducted, and the drug should be discontinued if abnormal signs are detected. Blood-related adverse reactions such as agranulocytosis or thrombocytopenia may also occur, so initial symptoms like sore throat, fatigue, and fever must be observed carefully. Rarely, severe side effects such as skin rash, convulsions, and heart block have been reported, so immediate consultation with a healthcare provider is advised if any unusual symptoms appear. Various side effects can occur in different areas such as the gastrointestinal tract, central nervous system, and circulatory system, so any discomfort during use should be reported. Patients with symptoms suspicious of malignant tumors must undergo testing, and if confirmed as malignant gastric cancer, the administration of this drug should be stopped. During treatment, the patient's condition should be monitored closely, and alternative therapies should be considered if no effect is observed. Elderly patients are at risk for decreased physical functions, so care must be taken in dosing and administration intervals. Dialysis patients may have increased serum concentrations, so starting with a low dose and careful administration is necessary. Pregnant women should only take this medication if the benefit outweighs the risk as determined by a physician, and breastfeeding women are advised to avoid this medication. The safety in children has not been sufficiently established, so use is preferably avoided. This medication should be stored out of reach of children and kept in its original container to prevent misuse or quality degradation.

• Shock
• anaphylaxis symptoms
• facial pallor
• low blood pressure
• generalized rash
• difficulty breathing
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 degrees Celsius and 30 degrees Celsius at room temperature.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle